PHX 8.11% 4.0¢ pharmx technologies limited

Ann: Annual Report to shareholders, page-2

  1. 4,196 Posts.
    lightbulb Created with Sketch. 459
    A positive report, particularly with some upbeat commentary from the Chairman and MD.

    Highlights for me included:
    - After tax profit of $251k in a year of transition
    - Corum Clear is fully developed and ready to be launched to the market
    - Other products developed (Safeguard and ARCScript) are contributing to revenue with take-up of 30% of customers. To me that says there are still potential targets for an upsell
    - Costs decreased over the year, Chairman suggests these could reduce by another 15% this year. This is roughly $2m off the current cost base, which post development of Corum Clear is understandable.
    - Targeting revenue growth of 10%, which combined with the cost savings, would see revenues of $14m and costs of $10m, so a potential $4m in net profit after tax without taking into account any one-offs.
    - Mergers and acqusitions are still being reviewed.
    - Cash at the end of this quarter is expected to be $6.7m

    For the first time in while, things are looking up. A good half year result and an interim dividends might even be on the cards.
 
watchlist Created with Sketch. Add PHX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.003(8.11%)
Mkt cap ! $23.94M
Open High Low Value Volume
3.9¢ 4.2¢ 3.9¢ $123.9K 3.084M

Buyers (Bids)

No. Vol. Price($)
1 1000000 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 111237 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PHX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.